Emerging Pharmacotherapies: The Future of Heart Failure Management

Article Figures & Data

Figures

  • Figure 1.

    EVEREST Objectives

    Reproduced with permission frm MA Konstam, MD.
  • Figure 2.

    Chronic PDE5 Inhibition Improves Left Ventricular Systolic Dysfunction

    LVEDV=left ventricular end diastolic volume; LVMI=left ventricular myocardial infarction; LVEF-left ventricular ejection fraction; PDE-5=phosphodiesterase type 5.*p<0.01 vs placebo; #p<0.01 vs baseline.Reproduced from Guazzi M et al. PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure: Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study. Circulation Heart Failure 2011;4(1)8–17.